Delivery Order SPE2DB20D3303-SPE2DB26FY2K5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,857.36 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Briviact 100 mg tablets (60 units) with a ceiling value of $5,180.03. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Briviact 100 mg tablets (60-count units) with a ceiling value of $2,957.36. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to complete by November 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Briviact 100 mg tablets (60-count packaging). This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,706.39 and an ultimate completion date of August 15, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Briviact 75 mg tablets (60-count units) under a firm fixed-price contract valued at $2,224.71. This non-set-aside award represents a child delivery order issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical support vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 50 mg tablets (60-count units) under a firm fixed-price contract valued at $2,538.23. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,601.40 to AmerisourceBergen Drug Corp for Briviact 50mg tablets (60-count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.62 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Briviact 50 mg tablets (60-count packaging). This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The contract specifies a place of performance in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. The order carries an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for 60-tablet units of Briviact 100 mg tablets with a ceiling value of $6,386.97. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under the company's larger indefinite delivery contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $3,263.43 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Briviact 100 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2K5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Briviact 50 mg tablets (60-count units) at a ceiling value of $1,055.99. This firm fixed price delivery order, with an ultimate completion date of November 7, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same municipality. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive capability in fulfilling medical procurement requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/6/25 |